HWNI members Helen Bateup, associate professor of neuroscience and molecular and cell biology, and David Schaffer, professor of chemical and biomolecular engineering and executive director of QB3, are part of a team of QB3 researchers from UC Berkeley, UC San Francisco, and UC Santa Cruz that has been awarded $12 million from the California Institute for Regenerative Medicine (CIRM) to investigate the genetic pathways underlying autism spectrum disorder (ASD). The researchers will use brain organoid models, clinical data, and AI tools to discover common pathways, protective factors, and biomarkers for different forms of autism. The project could advance understanding of ASD and lead to new treatments.
Read more from CIRM: https://www.cirm.ca.gov/about-cirm/newsroom/press-releases/cirm-awards-67-5-million-to-address-neuropsychiatric-diseases-through-its-remind-program/
